{"transactions":[{"id":922007,"issuer":{"id":4247,"kind":"organization","name":"MBX Biosciences, Inc."},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-03T21:16:29.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest and become exercisable in forty eight (48) equal monthly installments, beginning on March 2, 2026, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":39.07,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001193125-26-035584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776111/000119312526035584/ownership.xml","form_type":"4"}},{"id":922006,"issuer":{"id":4247,"kind":"organization","name":"MBX Biosciences, Inc."},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:16:29.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs will vest over a four (4) year period in equal quarterly installments, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001193125-26-035584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776111/000119312526035584/ownership.xml","form_type":"4"}},{"id":1281959,"issuer":{"id":4247,"kind":"organization","name":"MBX Biosciences, Inc."},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T21:17:21.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest and become exercisable on February 3, 2026, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":95000,"derivative":{"exercise_price":10.49,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0000950170-25-014497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776111/000095017025014497/ownership.xml","form_type":"4"}},{"id":1407720,"issuer":{"id":4247,"kind":"organization","name":"MBX Biosciences, Inc."},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-13T21:13:35.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":42578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":42578,"derivative":{"exercise_price":16,"expiration_date":"2034-09-11","underlying":"Common Stock","underlying_shares":42578},"source":{"system":"sec-edgar","filing":"0000950170-24-106467","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776111/000095017024106467/ownership.xml","form_type":"4"}},{"id":2330834,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-16T21:09:22.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards will vest quarterly over four years beginning on March 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 82,751 shares of common stock held, including 1,899 shares acquired in Esperion's Employee Stock Purchase Plan."}],"balance_after":82751,"source":{"system":"sec-edgar","filing":"0001628280-22-006408","document":"wf-form4_164746494792741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000162828022006408/wf-form4_164746494792741.xml","form_type":"4"}},{"id":2530774,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-01T20:48:31.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards will vest as follows: 50% shall vest upon CVOT public presentation of results; and 50% shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 43,852 shares of common stock held, including 1,535 shares acquired in Esperion's Employee Stock Purchase Plan."}],"balance_after":43852,"source":{"system":"sec-edgar","filing":"0001628280-21-021008","document":"wf-form4_163579969811780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000162828021021008/wf-form4_163579969811780.xml","form_type":"4"}},{"id":2650209,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2021-06-30T20:27:08.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance-Based Restricted Stock Unit represents a contingent right to receive one share of Esperion Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These shares were issued in connection with a reward of performance-based restricted stock units that will vest only if performance goals are achieved over a two-year period beginning July 1, 2021. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the two-year performance period."}],"balance_after":26400,"derivative":{"expiration_date":"2023-06-30","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001628280-21-013223","document":"wf-form4_162508481463795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000162828021013223/wf-form4_162508481463795.xml","form_type":"4"}},{"id":2650208,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-30T20:27:08.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be October 15, 2021."}],"balance_after":37500,"derivative":{"exercise_price":22.52,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001628280-21-013223","document":"wf-form4_162508481463795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000162828021013223/wf-form4_162508481463795.xml","form_type":"4"}},{"id":2890462,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-29T22:01:30.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest over a four (4) year period in equal quarterly installments, the first of which will be May 15, 2021."}],"balance_after":50000,"derivative":{"exercise_price":32.12,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001628280-21-001178","document":"wf-form4_161195766843462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000162828021001178/wf-form4_161195766843462.xml","form_type":"4"}},{"id":2890461,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-29T22:01:30.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest over a four (4) year period in equal quarterly installments, the first of which will be May 15, 2021."}],"balance_after":23617,"source":{"system":"sec-edgar","filing":"0001628280-21-001178","document":"wf-form4_161195766843462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000162828021001178/wf-form4_161195766843462.xml","form_type":"4"}},{"id":3323540,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-03T21:27:28.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":33900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award will vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2020."}],"balance_after":33900,"derivative":{"exercise_price":61.34,"expiration_date":"2020-01-02","underlying":"Common Stock","underlying_shares":33900},"source":{"system":"sec-edgar","filing":"0001179110-20-000170","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911020000170/edgar.xml","form_type":"4"}},{"id":3323539,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-03T21:27:28.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":7525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award will vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2020."}],"balance_after":18673,"source":{"system":"sec-edgar","filing":"0001179110-20-000170","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911020000170/edgar.xml","form_type":"4"}},{"id":3561439,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-05T21:23:59.000Z","date":"2019-04-03","kind":"sale","acquired":true,"shares":1500,"price":43.62,"value":65430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.46 to $43.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":11092,"source":{"system":"sec-edgar","filing":"0001179110-19-004803","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911019004803/edgar.xml","form_type":"4"}},{"id":3561438,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-05T21:23:59.000Z","date":"2019-04-03","kind":"sale","acquired":true,"shares":6500,"price":42.71,"value":277615.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":12592,"source":{"system":"sec-edgar","filing":"0001179110-19-004803","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911019004803/edgar.xml","form_type":"4"}},{"id":3747746,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-30T22:18:12.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four (4) year period in equal quarterly installments, the first of which will be on February 28, 2019."}],"balance_after":12000,"derivative":{"exercise_price":52.38,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-18-013334","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911018013334/edgar.xml","form_type":"4"}},{"id":4112652,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-03T23:01:45.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2018-04-24","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001179110-18-000394","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911018000394/edgar.xml","form_type":"4"}},{"id":4112651,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-03T23:01:45.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":38500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2018."}],"balance_after":38500,"derivative":{"exercise_price":66.5,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":38500},"source":{"system":"sec-edgar","filing":"0001179110-18-000394","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911018000394/edgar.xml","form_type":"4"}},{"id":4112650,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":67970,"kind":"person","name":"Bartram Richard","position":1,"cik":"0001723729","reported_name":"Bartram Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T23:01:45.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":17892,"price":3.7,"value":66200.4,"ownership":{"direct":true},"balance_after":19092,"source":{"system":"sec-edgar","filing":"0001179110-18-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723729/000117911018000394/edgar.xml","form_type":"4"}}]}